Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2013
03/21/2013US20130072447 Enhanced oral transcompartmental delivery of therapeutic or diaganostic agents
03/21/2013US20130072446 Anti-inflammatory pharmaceutical products
03/21/2013US20130072445 Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis
03/21/2013US20130072444 Organic compound for the regulation of vectorial ion channels
03/21/2013US20130072443 Stabilized mutant opsin proteins
03/21/2013US20130072442 Viral Complement Control Proteins for Eye Disorders
03/21/2013US20130072441 Protease Inhibitors and Preventives or Remedies for Disease
03/21/2013US20130072440 Co-crystals and pharmaceutical formulations comprising the same
03/21/2013US20130072439 Peptidomimetic macrocycles
03/21/2013US20130072438 Opioid peptide esters and methods of use
03/21/2013US20130072437 Neuregulin isoforms,neuregulin polypeptides and uses thereof
03/21/2013US20130072436 Process for manufacturing collagen and trace elements from sea water
03/21/2013US20130072435 Tribonectins
03/21/2013US20130072434 Inactivation resistant factor viii
03/21/2013US20130072433 Inhibitors of beta integrin-g protein alpha subunit binding interactions
03/21/2013US20130072432 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
03/21/2013US20130072430 Methods for treatment or prophylaxis of kidney or liver dysfunction
03/21/2013US20130072429 Assays and methods using biomarkers
03/21/2013US20130072427 Gpr 119 modulators
03/21/2013US20130072426 Diagnostic methods for obesity and related disorders
03/21/2013US20130072425 Saposin-a derived peptides and uses thereof
03/21/2013US20130072423 Cd44v6 peptides as inhibitors of bacterial infections
03/21/2013US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
03/21/2013US20130072403 Sperm-specific cation channel, catsper3, and uses therefor
03/21/2013US20130071484 Self-Assembled Toroidal-Spiral Particles and Manufacture and Uses Thereof
03/21/2013US20130071462 Drug Delivery Systems and Applications
03/21/2013US20130071457 Wound Healing Device
03/21/2013US20130071448 Treatment of t-cell mediated diseases
03/21/2013US20130071447 Methods for producing ecm-based biomaterials
03/21/2013US20130071443 Glycosaminoglycans
03/21/2013US20130071436 Treatment of t-cell mediated diseases
03/21/2013US20130071424 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein
03/21/2013US20130071416 Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
03/21/2013US20130071414 Engineered cd19-specific t lymphocytes that coexpress il-15 and an inducible caspase-9 based suicide gene for the treatment of b-cell malignancies
03/21/2013US20130071411 Iap bir domain binding compounds
03/21/2013US20130071407 Methods for modulating hematopoiesis and vascular growth
03/21/2013US20130071394 Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and methods of use
03/21/2013US20130071393 Methods for increasing red blood cell levels and treating anemia using a combination of gdf traps and erythropoietin receptor activators
03/21/2013US20130071392 Small Heat Shock Proteins and Active Fragments Thereof as a Therapy for Inflammation and Ischemia
03/21/2013US20130071391 Methods of Treating Glucose Metabolism Disorders
03/21/2013US20130071383 Selective modification of proteins
03/21/2013US20130071382 Egfr mutations
03/21/2013US20130071374 RNA Interferases and Methods of Use Thereof
03/21/2013US20130071373 Methods for the diagnosis and therapy of retinitis pigmentosa
03/21/2013US20130071372 Metallo-protein and tocotrienol (mp-t3) compositions with non-protein-type metal chelator and uses thereof
03/21/2013US20130071371 Method of Producing Physiological and Therapeutic Levels of Nitric Oxide Through an Oral Delivery System
03/21/2013US20130071366 Insulin-like growth factor ii (igf-ii) binding factors
03/21/2013US20130071362 Human placental collagen compositions, and methods of making and using the same
03/21/2013US20130071354 Modulators of toll-like receptors
03/21/2013US20130071353 Antiviral Compounds and Methods of Use Thereof
03/21/2013US20130071352 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
03/21/2013US20130071351 Combination therapy
03/21/2013US20130071350 Method and compositions for treatment of cancers
03/21/2013US20130071323 Therapies for hematologic malignancies
03/21/2013US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/21/2013CA2855781A1 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
03/21/2013CA2848919A1 Novel alpha 1-antitrypsin variant, preparation method thereof and use thereof
03/21/2013CA2848880A1 Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation
03/21/2013CA2848851A1 Wnt7a compositions and methods of using the same
03/21/2013CA2848841A1 Wnt compositions and therapeutic uses of such compositions
03/21/2013CA2848311A1 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells
03/21/2013CA2848230A1 Endoglycosidase from streptococcus pyogenes and methods using it
03/21/2013CA2848204A1 Glucagon-like peptide-2 compositions and methods of making and using same
03/21/2013CA2846608A1 Pseudomonas exotoxin a with less immunogenic b cell epitopes
03/20/2013EP2570432A1 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
03/20/2013EP2570431A2 Compositions and methods of using proislet peptides and analogs thereof
03/20/2013EP2570425A2 Deletions in domain II of Pseudomonas exotoxin A that reduce non-specific toxicity
03/20/2013EP2570422A2 Promiscuous HER-2/NEU CD4 T cell epitopes
03/20/2013EP2570136A2 Protein A compositions and methods of use
03/20/2013EP2570134A1 Systems and methods for diminishing cell growth and including selective killing of target cells
03/20/2013EP2570133A1 Glucagon analogs exhibiting physiological solubility and stability
03/20/2013EP2570131A1 Formulation against leishmaniasis and use thereof
03/20/2013EP2569433A1 Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion
03/20/2013EP2569424A1 Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
03/20/2013EP2569330A2 Chlorotoxin variants, conjugates, and methods for their use
03/20/2013EP2569327A1 Eif4e binding peptides
03/20/2013EP2569017A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
03/20/2013EP2569005A1 Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease
03/20/2013EP2569004A2 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
03/20/2013EP2569003A2 Parathyroid hormone analogs and uses thereof
03/20/2013EP2569002A1 Process for the preparation of insulin-zinc complexes
03/20/2013EP2569001A2 Methods for treatment or prophylaxis of kidney or liver dysfunction
03/20/2013EP2569000A1 Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
03/20/2013EP2568999A2 Acth for treatment of amyotrophic lateral sclerosis
03/20/2013EP2568998A1 Use of interferon alpha for the treatment of chronic kidney disease
03/20/2013EP2568997A2 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
03/20/2013EP2568996A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
03/20/2013EP2568995A1 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
03/20/2013EP2568994A2 Protease catalyzed in situ end capping of oligopeptides in aqueous media
03/20/2013EP2568993A1 Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
03/20/2013EP2345670B1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
03/20/2013EP1303259B1 Prolonged release microspheres for injection delivery and preparation method
03/20/2013CN1822846B Perivascular mesenchymal precursor cell induced blood vessel formation
03/20/2013CN1571834B Cell therapy method for the treatment of tumors
03/20/2013CN1541107B Growth factor complex
03/20/2013CN1441841B Stimulation of cellular regeneration and differentiation in inner ear
03/20/2013CN1371289B Gene therapy using TGF-beta
03/20/2013CN102985538A Lysosomal storage disease enzyme
03/20/2013CN102985439A IAP BIR domain binding compounds
03/20/2013CN102985112A Pharmaceutical composition for treatment and prevention of herpesvirus infections
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 3163